Persistence and adherence in multiple sclerosis patients starting glatiramer acetate treatment: assessment of relationship with care received from multiple disciplines
Peter Joseph Jongen,1,2 Wim A Lemmens,3 Raymond Hupperts,4 Erwin LJ Hoogervorst,5 Hans M Schrijver,6 Astrid Slettenaar,7 Els L de Schryver,8 Jan Boringa,9 Esther van Noort,10 Rogier Donders3 1Department of Community and Occupational Medicine, University Medical Centre Groningen, University Groninge...
Main Authors: | Jongen PJ, Lemmens WA, Hupperts R, Hoogervorst ELJ, Schrijver HM, Slettenaar A, de Schryver EL, Boringa J, van Noort E, Donders R |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-05-01
|
Series: | Patient Preference and Adherence |
Subjects: | |
Online Access: | https://www.dovepress.com/persistence-and-adherence-in-multiple-sclerosis-patients-starting-glat-peer-reviewed-article-PPA |
Similar Items
-
Drug adherence and multidisciplinary care in patients with multiple sclerosis: Protocol of a prospective, web-based, patient-centred, nation-wide, Dutch cohort study in glatiramer acetate treated patients (CAIR study)
by: Siepman Theodora, et al.
Published: (2011-03-01) -
The role of glatiramer acetate in the early treatment of multiple sclerosis
by: David W Brandes
Published: (2010-06-01) -
New features of glatiramer acetate for the treatment of remitting multiple sclerosis
by: N. Y. Lasch
Published: (2015-12-01) -
Pharmacoeconomic assessment of the effectiveness of glatiramer acetate (Copaxone®) in patients with multiple sclerosis
by: G. Ya. Shvarts
Published: (2005-06-01) -
Experience of Glatiramer Acetate in the Treatment of Relapsing-Remitting Multiple Sclerosis Patients
by: Özlem Taşkapılıoğlu, et al.
Published: (2012-03-01)